2016 New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

Category : Diagnostic and Biotech  | Published Date : Oct-2015 | Pages : 570
Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $4,350.

2016 New Frontiers in the Italian Cancer Diagnostics Market is VPGMarketResearchs new study of the major business opportunities emerging in the Italian cancer diagnostics market during the nextfive years. The report examines trends in the Italian cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Italy Market Overview

- Five-year test volume and sales projections.

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers.

- Estimated universe of laboratories performing cancer diagnostic testing.

- Cancer statistics, etiology and recent developments.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Biochemical Markers
- Oncogenes
- Growth Factors
- Hormones
- Colony Stimulating Factors
- Lymphokines
- Immunohistochemical Stains, and others.

- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,
Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,
Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,
Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,
Tissue Polypeptide Antigen, and others.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product
suppliers by individual test.

- Five-year test volume and sales forecasts
for major tumor markers by market segment, including:

- Hospitals
- Commercial/Private Laboratories

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers
used for cancer testing, including their operating characteristics,
features and selling prices.

Technology Assessment

- Assessment of latest molecular diagnostic methods,
biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,
chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies
and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.

Competitive Strategies

- Strategic assessments ofmajor suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.

- The companies analyzed in the report include

- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- DiaSorin
- Eiken Chemical

- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zilla

Contains 570 pages and 83 tables

Please fill in the form below to download a TOC

* Marked Fields are Mandatory
Name * :
Email ID * :
Name of Company :
Phone No * :
Message :
Security code * :
Can't read the image? click here to refresh
Publisher Name :

Published Reports
Squalane is of a molecular formula C30H62 and has a specific stereochemical conformation. Squalane is traditionally sourced from shark liver or refined olive oil. It is highly sought after by formulators, due to its emollient properties. It is a high-end moisturizing ingredient used as an emollient in ....
US $3480
Notes: Production, means the output of Genome Editing/Genome Engineering Revenue, means the sales value of Genome Editing/Genome Engineering This report studies Genome Editing/Genome Engineering in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses ....
US $2900
Notes: Sales, means the sales volume of Atomic Fluorescence Spectrometer (AFS) Revenue, means the sales value of Atomic Fluorescence Spectrometer (AFS) This report studies sales (consumption) of Atomic Fluorescence Spectrometer (AFS) in Europe market, especially in Germany, UK, France, Russia, Italy, ....
US $3900

Upcoming Reports
Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to detect an allergy, skin tests and blood tests are performed by the healthcare providers .
US $ 4148
A clinical chemistry analyzer is use to analyze blood serum, plasma, urine and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective potentiometry, and latex agglutination .
US $3390
Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing .
US $3390
Please Select Format
Data Pack: US $ 4350
Local PDF: US $ 6800
Global User: US $ 14700

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.